Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 4 receptor alpha (IL-4Rα) is the alpha chain of the interleukin-4 receptor, a type I transmembrane protein that plays a central role in immune regulation. It is ubiquitously expressed on both innate and adaptive immune cells and mediates signaling for both IL-4 and IL-13, which are key cytokines in type II immune responses. Its main functions include promoting differentiation of T helper type 2 (Th2) cells, regulating IgE antibody production in B cells, and alternative activation of macrophages. Recent evidence shows neuronal expression modulates synaptic transmission within the CNS. Allelic variations have been associated with atopic diseases, making it a target for therapies modulating allergic inflammation.
Antibodies or antagonists binding to IL-4Rα, blocking IL-4 and IL-13 signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 4 Receptor Alpha (IL-4Rα).